Replies to post #680469 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

tryn2,

Oncovir added value to themselves with patent protection extension and that also adds value to use with L and Direct. Let’s see what’s cooking in the next few months as we head into “The Zone” for major news and possible amplification from the lawsuit, journal articles, Flaskworks etc. Best wishes.

[learningcurve2020]

Wow, you soldiers sure are pushing the Poly ICLC hard even as NWBO never mentions it. Oncovir's been around a long time and has run dozens of combo trials with all sorts of biotechs. I don't find any similar agreement with NWBO as this one.

https://www.sec.gov/Archives/edgar/data/1457612/000145761218000019/ex1032_oncovirredacted.htm

[Gus1212]

Tryn2 - It is possible that a merger can be developed with a new stock symbol (company) therefore all the outstanding shares would be adjusted into the new
Company. Could this be a way to adjust the outstanding shares?